irasia.com - Investor Relations Asia Pacific
HOME

The United Laboratories International Holdings Limited
(Incorporated in the Cayman Islands with limited liability)

Press Releases       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2017-August-24
  • The United Laboratories International Holdings Limited Recorded A Turnaround with Profit in 2017 Interim Results, Maintained Outstanding Sales Performance of Recombinant Human Insulin Injection Products Officially Launched Insulin Glargine Injection to Drive Sales Growth in the Future (in PDF)
  • 2017-May-14
  • "United Laboratories USLEN" Insulin Glargin Gained Experts' Recognition and Recommendation, Successfully Won the Tender Through Bidding in Four China Provinces and Products are to be Rolled Out Gradually (in PDF)
  • 2017-March-23
  • The United Laboratories International Holdings Limited Announces 2016 Annual Results, Maintained Outstanding Performance of Recombinant Human Insulin Injection Products, Gained Approval to Produce Insulin Glargine for Injection and Drive Sales in the Future (in PDF)
  • 2016
  • 2016 Press Releases
  • 2015
  • 2015 Press Releases
  • 2014
  • 2014 Press Releases
  • 2013
  • 2013 Press Releases
  • 2012
  • 2012 Press Releases
  • 2011
  • 2011 Press Releases
  • 2010
  • 2010 Press Releases
  • 2009
  • 2009 Press Releases
  • 2008
  • 2008 Press Releases
  • 2007
  • 2007 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2017 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.